Project
Inflammatory response time course, HUVEC (Wada et al., 2009)
Navigation
Downloads
Results for SOX3_SOX2
Z-value: 2.13
Motif logo
Transcription factors associated with SOX3_SOX2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SOX3
|
ENSG00000134595.6 | SRY-box transcription factor 3 |
|
SOX2
|
ENSG00000181449.2 | SRY-box transcription factor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SOX3 | hg19_v2_chrX_-_139587225_139587234 | -0.33 | 1.1e-01 | Click! |
| SOX2 | hg19_v2_chr3_+_181429704_181429722 | 0.03 | 8.7e-01 | Click! |
Activity profile of SOX3_SOX2 motif
Sorted Z-values of SOX3_SOX2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr4_+_41614909 | 10.01 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr4_+_41614720 | 9.54 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
| chr4_+_41540160 | 8.44 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr19_+_10765699 | 7.02 |
ENST00000590009.1
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
| chr7_+_30960915 | 6.28 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
| chr4_+_144303093 | 6.00 |
ENST00000505913.1
|
GAB1
|
GRB2-associated binding protein 1 |
| chr8_-_80993010 | 5.61 |
ENST00000537855.1
ENST00000520527.1 ENST00000517427.1 ENST00000448733.2 ENST00000379097.3 |
TPD52
|
tumor protein D52 |
| chr15_-_82338460 | 5.35 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
| chr8_-_17579726 | 5.24 |
ENST00000381861.3
|
MTUS1
|
microtubule associated tumor suppressor 1 |
| chr9_-_123476719 | 5.03 |
ENST00000373930.3
|
MEGF9
|
multiple EGF-like-domains 9 |
| chr9_-_123476612 | 5.00 |
ENST00000426959.1
|
MEGF9
|
multiple EGF-like-domains 9 |
| chr3_+_141105235 | 4.84 |
ENST00000503809.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr4_-_159080806 | 4.83 |
ENST00000590648.1
|
FAM198B
|
family with sequence similarity 198, member B |
| chr1_+_185703513 | 4.67 |
ENST00000271588.4
ENST00000367492.2 |
HMCN1
|
hemicentin 1 |
| chr1_+_100111580 | 4.60 |
ENST00000605497.1
|
PALMD
|
palmdelphin |
| chr7_+_102553430 | 4.45 |
ENST00000339431.4
ENST00000249377.4 |
LRRC17
|
leucine rich repeat containing 17 |
| chr14_-_51027838 | 4.38 |
ENST00000555216.1
|
MAP4K5
|
mitogen-activated protein kinase kinase kinase kinase 5 |
| chr1_+_100111479 | 4.28 |
ENST00000263174.4
|
PALMD
|
palmdelphin |
| chr16_+_30406721 | 4.11 |
ENST00000320159.2
|
ZNF48
|
zinc finger protein 48 |
| chr4_+_55524085 | 4.02 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
| chr5_-_111091948 | 4.01 |
ENST00000447165.2
|
NREP
|
neuronal regeneration related protein |
| chr21_-_27945562 | 3.88 |
ENST00000299340.4
ENST00000435845.2 |
CYYR1
|
cysteine/tyrosine-rich 1 |
| chr4_-_186732048 | 3.72 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr9_-_74979420 | 3.62 |
ENST00000343431.2
ENST00000376956.3 |
ZFAND5
|
zinc finger, AN1-type domain 5 |
| chr4_-_186877502 | 3.50 |
ENST00000431902.1
ENST00000284776.7 ENST00000415274.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr7_+_16793160 | 3.41 |
ENST00000262067.4
|
TSPAN13
|
tetraspanin 13 |
| chrX_-_117107542 | 3.40 |
ENST00000371878.1
|
KLHL13
|
kelch-like family member 13 |
| chr1_+_164528866 | 3.40 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
| chr15_-_52944231 | 3.38 |
ENST00000546305.2
|
FAM214A
|
family with sequence similarity 214, member A |
| chr6_+_30848557 | 3.37 |
ENST00000460944.2
ENST00000324771.8 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr20_-_39317868 | 3.35 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
| chr3_+_151986709 | 3.27 |
ENST00000495875.2
ENST00000493459.1 ENST00000324210.5 ENST00000459747.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
| chr1_-_46598371 | 3.18 |
ENST00000372006.1
ENST00000425892.1 ENST00000420542.1 ENST00000354242.4 ENST00000340332.6 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
| chr3_-_18466026 | 3.18 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
| chr3_-_52719810 | 3.10 |
ENST00000424867.1
ENST00000394830.3 ENST00000431678.1 ENST00000450271.1 |
PBRM1
|
polybromo 1 |
| chr17_-_42276574 | 3.07 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr18_+_6729698 | 2.93 |
ENST00000383472.4
|
ARHGAP28
|
Rho GTPase activating protein 28 |
| chr8_-_48651648 | 2.80 |
ENST00000408965.3
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta |
| chr5_+_121647764 | 2.76 |
ENST00000261368.8
ENST00000379533.2 ENST00000379536.2 ENST00000379538.3 |
SNCAIP
|
synuclein, alpha interacting protein |
| chr2_+_33172221 | 2.71 |
ENST00000354476.3
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr2_+_69240302 | 2.68 |
ENST00000303714.4
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr1_+_47489240 | 2.62 |
ENST00000371901.3
|
CYP4X1
|
cytochrome P450, family 4, subfamily X, polypeptide 1 |
| chr5_+_121647924 | 2.60 |
ENST00000414317.2
|
SNCAIP
|
synuclein, alpha interacting protein |
| chr13_+_32605437 | 2.58 |
ENST00000380250.3
|
FRY
|
furry homolog (Drosophila) |
| chr11_-_10830463 | 2.54 |
ENST00000527419.1
ENST00000530211.1 ENST00000530702.1 ENST00000524932.1 ENST00000532570.1 |
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2 |
| chr8_-_6420565 | 2.46 |
ENST00000338312.6
|
ANGPT2
|
angiopoietin 2 |
| chr5_+_121647877 | 2.45 |
ENST00000514497.2
ENST00000261367.7 |
SNCAIP
|
synuclein, alpha interacting protein |
| chr12_+_93772402 | 2.44 |
ENST00000546925.1
|
NUDT4
|
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
| chrX_+_84499081 | 2.43 |
ENST00000276123.3
|
ZNF711
|
zinc finger protein 711 |
| chr9_+_82187630 | 2.41 |
ENST00000265284.6
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
| chr9_+_82187487 | 2.40 |
ENST00000435650.1
ENST00000414465.1 ENST00000376537.4 ENST00000376534.4 |
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
| chr12_-_6233828 | 2.39 |
ENST00000572068.1
ENST00000261405.5 |
VWF
|
von Willebrand factor |
| chr10_+_18948311 | 2.37 |
ENST00000377275.3
|
ARL5B
|
ADP-ribosylation factor-like 5B |
| chr4_+_156680143 | 2.28 |
ENST00000505154.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
| chr1_+_65886326 | 2.28 |
ENST00000371059.3
ENST00000371060.3 ENST00000349533.6 ENST00000406510.3 |
LEPR
|
leptin receptor |
| chr11_-_66445219 | 2.26 |
ENST00000525754.1
ENST00000531969.1 ENST00000524637.1 ENST00000531036.2 ENST00000310046.4 |
RBM4B
|
RNA binding motif protein 4B |
| chr17_-_14683517 | 2.25 |
ENST00000379640.1
|
AC005863.1
|
AC005863.1 |
| chr10_+_35484793 | 2.25 |
ENST00000488741.1
ENST00000474931.1 ENST00000468236.1 ENST00000344351.5 ENST00000490511.1 |
CREM
|
cAMP responsive element modulator |
| chr7_-_22233442 | 2.24 |
ENST00000401957.2
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chr9_+_91003271 | 2.23 |
ENST00000375859.3
ENST00000541629.1 |
SPIN1
|
spindlin 1 |
| chrX_+_15518923 | 2.22 |
ENST00000348343.6
|
BMX
|
BMX non-receptor tyrosine kinase |
| chr4_+_154387480 | 2.15 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
| chr2_-_238499303 | 2.14 |
ENST00000409576.1
|
RAB17
|
RAB17, member RAS oncogene family |
| chr3_-_65583561 | 2.08 |
ENST00000460329.2
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
| chr11_-_10829851 | 2.07 |
ENST00000532082.1
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2 |
| chr4_+_144258021 | 2.06 |
ENST00000262994.4
|
GAB1
|
GRB2-associated binding protein 1 |
| chrX_+_86772787 | 2.05 |
ENST00000373114.4
|
KLHL4
|
kelch-like family member 4 |
| chr14_-_50999190 | 2.01 |
ENST00000557390.1
|
MAP4K5
|
mitogen-activated protein kinase kinase kinase kinase 5 |
| chr7_-_32931623 | 1.98 |
ENST00000452926.1
|
KBTBD2
|
kelch repeat and BTB (POZ) domain containing 2 |
| chr1_+_66458072 | 1.98 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
| chr6_-_130031358 | 1.97 |
ENST00000368149.2
|
ARHGAP18
|
Rho GTPase activating protein 18 |
| chrX_+_84499038 | 1.96 |
ENST00000373165.3
|
ZNF711
|
zinc finger protein 711 |
| chr2_-_188312971 | 1.95 |
ENST00000410068.1
ENST00000447403.1 ENST00000410102.1 |
CALCRL
|
calcitonin receptor-like |
| chr3_-_141747439 | 1.93 |
ENST00000467667.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
| chr8_-_6420759 | 1.93 |
ENST00000523120.1
|
ANGPT2
|
angiopoietin 2 |
| chr6_-_107436473 | 1.91 |
ENST00000369042.1
|
BEND3
|
BEN domain containing 3 |
| chr8_-_124553437 | 1.91 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
| chr12_+_93772326 | 1.91 |
ENST00000550056.1
ENST00000549992.1 ENST00000548662.1 ENST00000547014.1 |
NUDT4
|
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
| chr2_-_208489707 | 1.90 |
ENST00000448007.2
ENST00000432416.1 ENST00000411432.1 |
METTL21A
|
methyltransferase like 21A |
| chr1_+_33231268 | 1.89 |
ENST00000373480.1
|
KIAA1522
|
KIAA1522 |
| chr1_+_182808474 | 1.88 |
ENST00000367549.3
|
DHX9
|
DEAH (Asp-Glu-Ala-His) box helicase 9 |
| chrX_+_84498989 | 1.88 |
ENST00000395402.1
|
ZNF711
|
zinc finger protein 711 |
| chr8_-_38326119 | 1.88 |
ENST00000356207.5
ENST00000326324.6 |
FGFR1
|
fibroblast growth factor receptor 1 |
| chr2_+_111880242 | 1.88 |
ENST00000393252.3
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator) |
| chr10_+_102106829 | 1.85 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
| chr4_+_146403912 | 1.85 |
ENST00000507367.1
ENST00000394092.2 ENST00000515385.1 |
SMAD1
|
SMAD family member 1 |
| chr4_-_90757364 | 1.84 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr4_-_90756769 | 1.84 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr1_-_182360498 | 1.84 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
| chr15_+_57210961 | 1.83 |
ENST00000557843.1
|
TCF12
|
transcription factor 12 |
| chr15_+_77224045 | 1.83 |
ENST00000320963.5
ENST00000394883.3 |
RCN2
|
reticulocalbin 2, EF-hand calcium binding domain |
| chr5_-_111092930 | 1.83 |
ENST00000257435.7
|
NREP
|
neuronal regeneration related protein |
| chr9_+_133971863 | 1.82 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
| chr4_+_78079450 | 1.82 |
ENST00000395640.1
ENST00000512918.1 |
CCNG2
|
cyclin G2 |
| chr21_-_27423339 | 1.81 |
ENST00000415997.1
|
APP
|
amyloid beta (A4) precursor protein |
| chr6_+_132455118 | 1.81 |
ENST00000458028.1
|
LINC01013
|
long intergenic non-protein coding RNA 1013 |
| chr9_+_133971909 | 1.80 |
ENST00000247291.3
ENST00000372302.1 ENST00000372300.1 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1-like |
| chr2_-_26205340 | 1.80 |
ENST00000264712.3
|
KIF3C
|
kinesin family member 3C |
| chr19_-_49864746 | 1.79 |
ENST00000598810.1
|
TEAD2
|
TEA domain family member 2 |
| chr4_+_156680153 | 1.78 |
ENST00000502959.1
ENST00000505764.1 ENST00000507146.1 ENST00000264424.8 ENST00000503520.1 |
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
| chr13_-_107187462 | 1.75 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
| chr6_+_155537771 | 1.72 |
ENST00000275246.7
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2 |
| chr8_-_38325219 | 1.72 |
ENST00000533668.1
ENST00000413133.2 ENST00000397108.4 ENST00000526742.1 ENST00000525001.1 ENST00000425967.3 ENST00000529552.1 ENST00000397113.2 |
FGFR1
|
fibroblast growth factor receptor 1 |
| chr4_+_78079570 | 1.71 |
ENST00000509972.1
|
CCNG2
|
cyclin G2 |
| chr4_+_78078304 | 1.71 |
ENST00000316355.5
ENST00000354403.5 ENST00000502280.1 |
CCNG2
|
cyclin G2 |
| chr13_+_111767650 | 1.69 |
ENST00000449979.1
ENST00000370623.3 |
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
| chr8_+_68864330 | 1.68 |
ENST00000288368.4
|
PREX2
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
| chr8_-_6420777 | 1.68 |
ENST00000415216.1
|
ANGPT2
|
angiopoietin 2 |
| chr1_+_61330931 | 1.67 |
ENST00000371191.1
|
NFIA
|
nuclear factor I/A |
| chr3_-_141747950 | 1.67 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
| chr8_-_6420930 | 1.66 |
ENST00000325203.5
|
ANGPT2
|
angiopoietin 2 |
| chrX_-_134049233 | 1.65 |
ENST00000370779.4
|
MOSPD1
|
motile sperm domain containing 1 |
| chr7_+_77167343 | 1.65 |
ENST00000433369.2
ENST00000415482.2 |
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
| chr1_-_85930246 | 1.64 |
ENST00000426972.3
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr5_-_111093167 | 1.64 |
ENST00000446294.2
ENST00000419114.2 |
NREP
|
neuronal regeneration related protein |
| chrX_+_80457442 | 1.64 |
ENST00000373212.5
|
SH3BGRL
|
SH3 domain binding glutamic acid-rich protein like |
| chr17_+_65374075 | 1.63 |
ENST00000581322.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
| chr20_-_4804244 | 1.63 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
| chr16_-_46864955 | 1.63 |
ENST00000565112.1
|
C16orf87
|
chromosome 16 open reading frame 87 |
| chr5_-_111092873 | 1.63 |
ENST00000509025.1
ENST00000515855.1 |
NREP
|
neuronal regeneration related protein |
| chr6_-_75915757 | 1.61 |
ENST00000322507.8
|
COL12A1
|
collagen, type XII, alpha 1 |
| chr11_+_125034586 | 1.61 |
ENST00000298282.9
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
| chr5_-_111093081 | 1.60 |
ENST00000453526.2
ENST00000509427.1 |
NREP
|
neuronal regeneration related protein |
| chr7_+_116312411 | 1.60 |
ENST00000456159.1
ENST00000397752.3 ENST00000318493.6 |
MET
|
met proto-oncogene |
| chrX_-_45060135 | 1.59 |
ENST00000398000.2
ENST00000377934.4 |
CXorf36
|
chromosome X open reading frame 36 |
| chr5_+_148960931 | 1.58 |
ENST00000333677.6
|
ARHGEF37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
| chr5_+_140797296 | 1.58 |
ENST00000398594.2
|
PCDHGB7
|
protocadherin gamma subfamily B, 7 |
| chr18_+_3448455 | 1.58 |
ENST00000549780.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr10_-_91174215 | 1.58 |
ENST00000371837.1
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase |
| chr14_+_91580777 | 1.58 |
ENST00000525393.2
ENST00000428926.2 ENST00000517362.1 |
C14orf159
|
chromosome 14 open reading frame 159 |
| chr1_+_40915725 | 1.57 |
ENST00000484445.1
ENST00000411995.2 ENST00000361584.3 |
ZFP69B
|
ZFP69 zinc finger protein B |
| chr14_+_91581011 | 1.57 |
ENST00000523894.1
ENST00000522322.1 ENST00000523771.1 |
C14orf159
|
chromosome 14 open reading frame 159 |
| chr7_+_115850547 | 1.57 |
ENST00000358204.4
ENST00000455989.1 ENST00000537767.1 |
TES
|
testis derived transcript (3 LIM domains) |
| chr3_+_183353356 | 1.57 |
ENST00000242810.6
ENST00000493074.1 ENST00000437402.1 ENST00000454495.2 ENST00000473045.1 ENST00000468101.1 ENST00000427201.2 ENST00000482138.1 ENST00000454652.2 |
KLHL24
|
kelch-like family member 24 |
| chr3_-_125820348 | 1.56 |
ENST00000509064.1
ENST00000508835.1 |
SLC41A3
|
solute carrier family 41, member 3 |
| chr1_+_66999268 | 1.55 |
ENST00000371039.1
ENST00000424320.1 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
| chr22_-_37880543 | 1.54 |
ENST00000442496.1
|
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr5_-_39425222 | 1.53 |
ENST00000320816.6
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
| chr17_-_76123101 | 1.53 |
ENST00000392467.3
|
TMC6
|
transmembrane channel-like 6 |
| chr13_-_99667960 | 1.51 |
ENST00000448493.2
|
DOCK9
|
dedicator of cytokinesis 9 |
| chr6_+_132455526 | 1.51 |
ENST00000443303.1
|
LINC01013
|
long intergenic non-protein coding RNA 1013 |
| chr3_-_128690173 | 1.51 |
ENST00000508239.1
|
RP11-723O4.6
|
Uncharacterized protein FLJ43738 |
| chr4_+_144257915 | 1.50 |
ENST00000262995.4
|
GAB1
|
GRB2-associated binding protein 1 |
| chr2_+_33172012 | 1.47 |
ENST00000404816.2
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr8_-_29940464 | 1.47 |
ENST00000521265.1
ENST00000536273.1 |
TMEM66
|
transmembrane protein 66 |
| chr14_+_77228532 | 1.46 |
ENST00000167106.4
ENST00000554237.1 |
VASH1
|
vasohibin 1 |
| chr16_+_11762270 | 1.46 |
ENST00000329565.5
|
SNN
|
stannin |
| chr22_-_36357671 | 1.46 |
ENST00000408983.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr15_+_77223960 | 1.45 |
ENST00000394885.3
|
RCN2
|
reticulocalbin 2, EF-hand calcium binding domain |
| chr2_-_208489275 | 1.44 |
ENST00000272839.3
ENST00000426075.1 |
METTL21A
|
methyltransferase like 21A |
| chrX_+_55744228 | 1.44 |
ENST00000262850.7
|
RRAGB
|
Ras-related GTP binding B |
| chr19_-_19051927 | 1.41 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr14_+_91580708 | 1.40 |
ENST00000518868.1
|
C14orf159
|
chromosome 14 open reading frame 159 |
| chr14_+_96505659 | 1.39 |
ENST00000555004.1
|
C14orf132
|
chromosome 14 open reading frame 132 |
| chr15_-_73075964 | 1.39 |
ENST00000563907.1
|
ADPGK
|
ADP-dependent glucokinase |
| chr5_-_39425068 | 1.38 |
ENST00000515700.1
ENST00000339788.6 |
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
| chr14_-_88459503 | 1.38 |
ENST00000393568.4
ENST00000261304.2 |
GALC
|
galactosylceramidase |
| chr13_-_41593425 | 1.37 |
ENST00000239882.3
|
ELF1
|
E74-like factor 1 (ets domain transcription factor) |
| chr14_-_91884115 | 1.36 |
ENST00000389857.6
|
CCDC88C
|
coiled-coil domain containing 88C |
| chr11_+_68080077 | 1.36 |
ENST00000294304.7
|
LRP5
|
low density lipoprotein receptor-related protein 5 |
| chr8_+_86121448 | 1.36 |
ENST00000520225.1
|
E2F5
|
E2F transcription factor 5, p130-binding |
| chr1_+_93913713 | 1.36 |
ENST00000604705.1
ENST00000370253.2 |
FNBP1L
|
formin binding protein 1-like |
| chr16_+_67063262 | 1.34 |
ENST00000565389.1
|
CBFB
|
core-binding factor, beta subunit |
| chr3_-_112360116 | 1.34 |
ENST00000206423.3
ENST00000439685.2 |
CCDC80
|
coiled-coil domain containing 80 |
| chr6_+_89790459 | 1.33 |
ENST00000369472.1
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
| chr3_+_141043050 | 1.33 |
ENST00000509842.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr2_+_169923577 | 1.33 |
ENST00000432060.2
|
DHRS9
|
dehydrogenase/reductase (SDR family) member 9 |
| chr14_-_100772767 | 1.32 |
ENST00000392908.3
ENST00000539621.1 |
SLC25A29
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
| chr8_-_38326139 | 1.32 |
ENST00000335922.5
ENST00000532791.1 ENST00000397091.5 |
FGFR1
|
fibroblast growth factor receptor 1 |
| chr3_+_182983090 | 1.32 |
ENST00000465010.1
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
| chr2_+_177015950 | 1.32 |
ENST00000306324.3
|
HOXD4
|
homeobox D4 |
| chr5_-_39425290 | 1.32 |
ENST00000545653.1
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
| chr5_-_111093759 | 1.31 |
ENST00000509979.1
ENST00000513100.1 ENST00000508161.1 ENST00000455559.2 |
NREP
|
neuronal regeneration related protein |
| chr4_-_99578776 | 1.31 |
ENST00000515287.1
|
TSPAN5
|
tetraspanin 5 |
| chr16_-_15736881 | 1.30 |
ENST00000540441.2
|
KIAA0430
|
KIAA0430 |
| chr7_-_5569588 | 1.29 |
ENST00000417101.1
|
ACTB
|
actin, beta |
| chr6_+_126240442 | 1.29 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
| chr2_-_165424973 | 1.29 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
| chr6_-_35656685 | 1.29 |
ENST00000539068.1
ENST00000540787.1 |
FKBP5
|
FK506 binding protein 5 |
| chr9_-_14313641 | 1.29 |
ENST00000380953.1
|
NFIB
|
nuclear factor I/B |
| chr12_+_93963590 | 1.28 |
ENST00000340600.2
|
SOCS2
|
suppressor of cytokine signaling 2 |
| chr13_+_111365602 | 1.28 |
ENST00000333219.7
|
ING1
|
inhibitor of growth family, member 1 |
| chr9_+_124103625 | 1.27 |
ENST00000594963.1
|
AL161784.1
|
Uncharacterized protein |
| chr1_-_201123546 | 1.27 |
ENST00000435310.1
ENST00000485839.2 ENST00000367330.1 |
TMEM9
|
transmembrane protein 9 |
| chr1_-_201123586 | 1.26 |
ENST00000414605.2
ENST00000367334.5 ENST00000367332.1 |
TMEM9
|
transmembrane protein 9 |
| chr7_+_107224364 | 1.26 |
ENST00000491150.1
|
BCAP29
|
B-cell receptor-associated protein 29 |
| chr14_-_100772862 | 1.25 |
ENST00000359232.3
|
SLC25A29
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
| chrX_+_55744166 | 1.25 |
ENST00000374941.4
ENST00000414239.1 |
RRAGB
|
Ras-related GTP binding B |
| chrX_+_135229600 | 1.24 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr7_-_22234381 | 1.23 |
ENST00000458533.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chrX_+_86772707 | 1.23 |
ENST00000373119.4
|
KLHL4
|
kelch-like family member 4 |
| chr6_-_35656712 | 1.23 |
ENST00000357266.4
ENST00000542713.1 |
FKBP5
|
FK506 binding protein 5 |
| chr13_+_111855414 | 1.22 |
ENST00000375737.5
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
| chr9_+_103235365 | 1.22 |
ENST00000374879.4
|
TMEFF1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
| chr15_-_59665062 | 1.22 |
ENST00000288235.4
|
MYO1E
|
myosin IE |
| chr7_-_19813192 | 1.21 |
ENST00000422233.1
ENST00000433641.1 |
TMEM196
|
transmembrane protein 196 |
| chr6_+_160183492 | 1.21 |
ENST00000541436.1
|
ACAT2
|
acetyl-CoA acetyltransferase 2 |
| chr14_+_53019993 | 1.20 |
ENST00000542169.2
ENST00000555622.1 |
GPR137C
|
G protein-coupled receptor 137C |
| chr15_-_70994612 | 1.20 |
ENST00000558758.1
ENST00000379983.2 ENST00000560441.1 |
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
| chr14_+_63671105 | 1.20 |
ENST00000316754.3
|
RHOJ
|
ras homolog family member J |
Network of associatons between targets according to the STRING database.
First level regulatory network of SOX3_SOX2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 6.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 1.9 | 7.7 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 1.6 | 4.9 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 1.3 | 4.0 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.2 | 3.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.2 | 3.5 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 1.1 | 3.4 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 1.1 | 4.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.9 | 2.6 | GO:1902024 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.8 | 5.8 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.8 | 2.4 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.8 | 2.4 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.7 | 6.7 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.7 | 4.3 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.6 | 1.9 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.6 | 1.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.6 | 1.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.6 | 1.8 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.6 | 1.8 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.6 | 2.9 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.5 | 4.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.5 | 2.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.5 | 1.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.5 | 0.5 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.4 | 4.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.4 | 3.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 | 1.2 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.4 | 1.6 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.4 | 0.4 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.4 | 2.3 | GO:1990822 | regulation of arginine metabolic process(GO:0000821) basic amino acid transmembrane transport(GO:1990822) |
| 0.4 | 1.2 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.4 | 1.9 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 0.4 | 1.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.4 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.4 | 2.2 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.4 | 1.8 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.4 | 1.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.4 | 1.1 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.3 | 1.0 | GO:0003250 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.3 | 1.0 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.3 | 2.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.3 | 2.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.3 | 2.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.3 | 1.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 | 0.9 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.3 | 0.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.3 | 1.8 | GO:0030421 | defecation(GO:0030421) |
| 0.3 | 2.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.3 | 1.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 | 1.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 | 2.9 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 | 1.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.3 | 1.1 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.3 | 1.3 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.3 | 1.0 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.3 | 1.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 | 0.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.3 | 1.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 | 1.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 | 1.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 1.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 | 9.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.2 | 2.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 0.2 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.2 | 2.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.2 | 0.4 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.2 | 2.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 1.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.2 | 0.6 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.2 | 0.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 | 0.6 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 | 1.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.2 | 3.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 | 0.6 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.2 | 2.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.2 | 6.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
| 0.2 | 0.6 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.2 | 0.8 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.2 | 2.3 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.2 | 0.6 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.2 | 0.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.2 | 1.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.2 | 0.6 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.2 | 6.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 1.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.2 | 0.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.2 | 1.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 4.0 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.2 | 1.9 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 0.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.2 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 1.9 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 | 1.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 1.7 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.2 | 2.8 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 | 1.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.2 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.2 | 0.8 | GO:1901377 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.2 | 1.7 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.2 | 4.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.2 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 | 2.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 0.7 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 | 0.4 | GO:1904247 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.1 | 3.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 0.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 2.3 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 | 0.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.9 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.1 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 | 0.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.1 | 2.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.1 | 0.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.3 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.1 | 0.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 1.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 4.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 | 1.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 0.7 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 | 1.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 | 3.1 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 | 1.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 2.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 5.4 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.1 | 0.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.4 | GO:0018032 | protein amidation(GO:0018032) |
| 0.1 | 0.3 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 2.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 3.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 1.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 5.4 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.8 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 0.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 | 1.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 | 0.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.1 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.1 | 0.8 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 | 1.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 1.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.3 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.4 | GO:0009597 | detection of virus(GO:0009597) |
| 0.1 | 1.5 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 0.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 4.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 0.3 | GO:0033128 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
| 0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.1 | 0.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.1 | 1.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 0.3 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 0.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.1 | 0.4 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 0.6 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.1 | 1.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.1 | 2.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.1 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 1.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 3.3 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 0.9 | GO:1902961 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 1.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 26.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.1 | 1.3 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.1 | 0.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 | 0.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.1 | 1.4 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 | 0.2 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.1 | 1.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 0.2 | GO:1903336 | intralumenal vesicle formation(GO:0070676) negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.5 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.1 | 0.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 0.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.1 | 0.2 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 | 0.4 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.1 | 0.4 | GO:1905049 | regulation of Rap protein signal transduction(GO:0032487) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.1 | 1.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 0.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.1 | 0.3 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.1 | 0.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 2.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 0.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.1 | 0.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 | 0.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.1 | 0.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 0.4 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.1 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 3.8 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 | 3.0 | GO:0060324 | face development(GO:0060324) |
| 0.1 | 0.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.1 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.1 | 0.1 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 | 0.2 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.1 | 1.0 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 1.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.4 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 0.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 2.4 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 | 2.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.1 | 0.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 1.9 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.0 | 0.1 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.0 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 0.0 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 | 0.3 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 | 1.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 2.9 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.0 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.0 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 9.3 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.0 | 1.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.0 | 0.5 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 2.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 | 0.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 | 0.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.0 | 0.2 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.0 | 0.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.0 | 0.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 3.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 1.2 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 0.1 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.0 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 0.3 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.0 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.0 | 0.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.0 | 6.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.2 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.0 | 1.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 1.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 1.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 1.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.0 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
| 0.0 | 0.2 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 | 0.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.0 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 | 0.9 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
| 0.0 | 0.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.0 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.0 | 0.4 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 1.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.0 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 | 0.1 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.0 | 0.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 1.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 | 1.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.0 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.0 | 0.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.9 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 0.0 | 1.7 | GO:0019079 | viral genome replication(GO:0019079) |
| 0.0 | 0.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.0 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
| 0.0 | 0.1 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 0.4 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) |
| 0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.0 | 1.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.0 | 0.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 0.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.0 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 | 0.7 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.0 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.0 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.0 | 0.3 | GO:0015866 | ADP transport(GO:0015866) |
| 0.0 | 0.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 | 1.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 1.3 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.0 | 0.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.0 | 0.4 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 | 0.1 | GO:0052314 | response to pyrethroid(GO:0046684) phytoalexin metabolic process(GO:0052314) |
| 0.0 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.0 | 0.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 | 0.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.5 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
| 0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 1.0 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.0 | 0.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 1.5 | GO:0009267 | cellular response to starvation(GO:0009267) |
| 0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 | 0.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.0 | 1.4 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.6 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.0 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.0 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.0 | 0.2 |